Gemina Laboratories Ltd GLABF
$0.05 $0.01 (16.67%) 1D
Last Updated: Dec 31, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
GLABF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Gemina Laboratories Ltd is classified as doubtful.
DOUBTFUL
Report Source: undefined Quarter Report
Gemina Laboratories Ltd. Stock Analysis GLABF
United States N/A Nano Cap Gemina Laboratories Ltd. engages in the development of biotechnology in the In Vitro Diagnostics and human wellness monitoring market under the name “Gemina Labs.” Its products include LEGIO X, LEGIO XI, Respiratory Syncytial Virus, and Tuberculosis. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. The firm is a biosensor and binding technologies company with a transformative, patented, proprietary chemistry that powers testing platforms for a range of pathogens that affect human health and wellness. The firm operates in the in vitro diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company operates within a single segment, being the research, development and commercialization of in-vitro diagnostics. Its technologies include dual affinity binding mechanism, gold binding protein, cellulose binding protein and more surface binding proteins. Its products include LEGIO X, which is a COVID-19 rapid antigen test, and LEGIO XI, which is a multiplex device that can detect and distinguish between influenza types A and B with no cross reactivity. LEGIO products in development include respiratory syncytial virus and tuberculosis.
Gemina Laboratories Ltd (GLABF) Chart
Financial Metrics & Statements of Gemina Laboratories Ltd (GLABF)
FAQ's for Gemina Laboratories Ltd (GLABF)
- As of August 2026, Gemina Laboratories Ltd GLABF is classified as doubtful according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Gemina Laboratories Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Gemina Laboratories Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Gemina Laboratories Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Gemina Laboratories Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Gemina Laboratories Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Gemina Laboratories Ltd (GLABF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
